Sarepta Therapeutics | SRPT - Ativo Circulante





Ativo Circulante Alterar Data
Acadia Pharmaceuticals USD 1.1B 33.9M 2026-03
Agios Pharmaceuticals USD 834.84M 107.21M 2026-03
Alnylam Pharmaceuticals USD 4.22B 168.65M 2026-03
Amgen USD 31.48B 2.42B 2026-03
BioCryst Pharmaceuticals USD 373.62M 30.72M 2026-03
Biogen USD 9.19B 216.3M 2026-03
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Capricor Therapeutics USD 283.09M 39.85M 2026-03
Daiichi Sankyo JPY 2.1T 218.5B 2025-12
Eli Lilly USD 54.84B 794M 2026-03
Esperion Therapeutics USD 459.46M 3.11M 2026-03
Gilead Sciences USD 18.64B 1.25B 2026-03
Incyte USD 5.48B 460.36M 2026-03
Insmed USD 1.61B 181.04M 2026-03
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
Moderna USD 5.77B 774M 2026-03
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Neurocrine Biosciences USD 2.44B 86.6M 2026-03
Novavax USD 850.82M 127.46M 2026-03
Pfizer USD 42.82B 76M 2026-03
PTC Therapeutics USD 2.25B 19.94M 2026-03
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sanofi EUR 30.16B 789M 2026-03
Sarepta Therapeutics USD 2.31B 228.06M 2026-03
Tectonic Therapeutic USD 239.89M 17.47M 2026-03
Ultragenyx Pharmaceutical USD 657M 294M 2026-03
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03